Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.775 USD | +5.22% | +11.29% | -11.51% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.51% | 1.98B | |
-1.72% | 104B | |
+6.49% | 97.47B | |
+5.71% | 22.25B | |
-12.63% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.02% | 16.36B | |
+6.92% | 14.39B | |
+37.06% | 12.37B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals : Gets FDA Orphan Drug Designation for Potential Treatment of Familial Adenomatous Polyposis